Patient Guide: eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 72 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT02767804
Status: ACTIVE_NOT_RECRUITING
Condition: Non-small Cell Lung Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 72 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Tampa, Florida
  • Athens, Georgia
  • St Louis, Missouri
  • • And 69 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily